Haleon plc (HLN) stock
Close on Nov 12, 2026Market cap $40.69BP/E 18.4Yield –
Haleon plc saw revenue fall 1.8% to £11.03B over fiscal 2025. Operating income rose 9.3% to £2.41B, moving the operating margin from 19.6% to 21.9%. Free cash flow was £2.31B, up 12.7% from a year earlier. At the latest close the market valued the company at £30.43B, 18.4 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- £30.43B
- P/E ratio
- 18.4
- Price to sales
- 2.76
- Price to book
- 1.86
- Dividend yield
- –
- Free cash flow yield
- 7.60%
Fundamentals
- Revenue
- £11.03B
- Net income
- £1.67B
- EPS, diluted
- 0.18 GBP
- Free cash flow
- £2.31B
Trading
- Previous close
- $9.10
- Open
- $9.16
- Day's range
- $9.06 – $9.19
- Volume
- 18,244,890
- Average volume (20 days)
- 23,278,920
- Beta (5 years)
- 0.17
- RSI (14 days)
- 44.2
- Volatility (1 year)
- 27.6%
- Relative volume
- 1.15×
- WACC
- 6.6%
Market cap history
Month-end market cap since 2022, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | HLN | S&P 500 | Difference | HLN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.3% | -2.7% | −1.6 pts | ||
| 3 months | -6.6% | -1.7% | −4.9 pts | ||
| Year to date | -8.3% | +11.9% | −20.2 pts | ||
| 1 year | -6.2% | +12.0% | −18.1 pts | ||
| 3 years | +18.7% | +78.2% | −59.5 pts | +5.9% | +21.2% |
Six years at a glance
Fiscal years 2020 to 2025, GBP
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Haleon filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Haleon
Perfumes, Cosmetics & Other Toilet Preparations
Haleon operates as a consumer healthcare company offering products across oral health, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements. The business delivers therapeutic skin health treatments, over-the-counter wellness solutions, and personal care products under brands such as Nexium, ChapStick, and Preparation H to individual consumers globally.
Company profile, executives and historyHaleon stock: common questions
What is Haleon's stock price?
HLN closed at $9.09 on Nov 12, 2026, down 0.11% on the day.
What is Haleon's market cap?
Haleon was worth $40.69B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is HLN's P/E ratio?
HLN trades at 18.4 times earnings, based on diluted earnings per share of 0.18 GBP over fiscal 2025.
How much revenue does Haleon make?
Haleon reported revenue of £11.03B for fiscal 2025, down 1.8% from a year earlier.
Does Haleon pay a dividend?
No. Haleon has not paid a cash dividend over the last twelve months.
How has HLN stock performed over the past year?
Including dividends, HLN returned -6.2% over the past year, against +12.0% for the S&P 500.
Who are Haleon's competitors?
Companies most similar to Haleon by business, industry and size include KVUE, CL, EL, COTY, YSG.
See a number that looks wrong?